A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
Marie King(University of Massachusetts Chan Medical School), Dale L. Greiner(University of Massachusetts Chan Medical School), Todd Pearson(University of Massachusetts Chan Medical School), Leonard D. Shultz(Jackson Laboratory), Madelyn R. Schmidt(University of Massachusetts Chan Medical School), Rita Bottino(Children's Hospital of Pittsburgh), Michael Thompson(University of Massachusetts Chan Medical School), Mark A. Atkinson(University of Florida), Robert T. Woodland(University of Massachusetts Chan Medical School), Clive Wasserfall(University of Florida), Aldo A. Rossini(University of Massachusetts Chan Medical School), Jean Leif(University of Massachusetts Chan Medical School), Massimo Trucco(Cleveland Clinic), Bruce A. Woda(University of Massachusetts Chan Medical School), Kevan C. Herold(Yale University)
Cited by 166
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k